Both carboxy- and amino-terminal domains of the vaccinia virus interferon resistance gene, E3L, are required for pathogenesis in a mouse model

Journal of Virology

Volumn 75, Issue 2, 2001, Pages 850-856

  Brandt, T A ^a   Jacobs, B L ^a  

^a ARIZONA STATE UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

INTERFERON; UNCLASSIFIED DRUG; VIRUS PROTEIN; VIRUS PROTEIN E3L;

AMINO TERMINAL SEQUENCE; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CARBOXY TERMINAL SEQUENCE; CONTROLLED STUDY; FEMALE; HUMAN; HUMAN CELL; MALE; MOUSE; NONHUMAN; PRIORITY JOURNAL; VACCINIA VIRUS; VIRUS PATHOGENESIS; VIRUS VIRULENCE; WEIGHT REDUCTION;

ANIMALS; BRAIN; DISEASE MODELS, ANIMAL; DRUG RESISTANCE, MICROBIAL; GENES, VIRAL; HUMANS; INTERFERONS; MICE; MICE, INBRED C57BL; PROTEIN STRUCTURE, TERTIARY; RNA-BINDING PROTEINS; VACCINIA; VACCINIA VIRUS; VIRAL PROTEINS; VIRULENCE; VIRUS REPLICATION; WEIGHT LOSS;

EID: 0035158662     PISSN: 0022538X     EISSN: None     Source Type: Journal    
DOI: 10.1128/JVI.75.2.850-856.2001     Document Type: Article

References (50)

1. Binding properties of newly identified Xenopus proteins containing dsRNA-binding motifs
2. Host-range restriction of vaccinia virus E3L-specific deletion mutants
3. Identification and characterization of two nonessential regions of the rabbitpox virus genome involved in virulence
4. Poxvirus pathogenesis
5. NMR solution structure of a dsRNA binding domain from Drosophila staufen protein reveals homology to the N-terminal domain of ribosomal protein S5
6. Identification of a conserved motif that is necessary for binding of the vaccinia virus E3L gene products to double-stranded RNA
7. Rescue of vaccinia virus lacking the E3L gene by mutants of E3L
8. The E3L gene of vaccinia virus encodes an inhibitor of the interferon-induced, double-stranded RNA-dependent protein kinase
9. A general method for the construction of recombinant vaccinia viruses expressing multiple foreign genes
10. The E3L and K3L vaccinia virus gene products stimulate translation through inhibition of the double-stranded RNA-dependent protein kinase by different mechanisms
11. Cloning of DLM-1, a novel gene that is up-regulated in activated macrophages, using RNA differential display
12. RNA binding and modulation of PKR activity
13. Immunomodulation by virulence proteins of the parapoxvirus orf virus
14. Physical and functional characterization of the double-stranded RNA binding protein encoded by the vaccinia virus E3 gene
15. 2-terminal kinase by double-stranded RNA and encephalomyocarditis virus: Involvement of RNase L, protein kinase R, and alternative pathways
16. Characterization of viral double-stranded RNA-binding proteins
17. An update on the vaccinia virus genome
18. Vaccinia virus: A suitable vehicle for recombinant vaccines?
19. Double-stranded RNA is a trigger for apoptosis in vaccinia virus-infected cells
20. Mapping and insertional mutagenesis of a vaccinia virus gene encoding a 13,800-Da secreted protein
21. Products of the porcine group C rotavirus NSP3 gene bind specifically to double-stranded RNA and inhibit activation of the interferon-induced protein kinase PKR
22. Functionally distinct double-stranded RNA-binding domains associated with alternative splice site variants of the interferon-inducible double-stranded RNA-specific adenosine deaminase
23. Double-stranded RNA-specific adenosine deaminase: Nucleic acid binding properties
24. Mechanism of interferon action: RNA-binding activity of full-length and R-domain forms of the RNA-dependent protein kinase PKR-determination of KD values for VAI and TAR RNAs
25. New strategies of immune modulation by DNA viruses
26. Interruption of cytokine networks by poxviruses: Lessons from myxoma virus
27. Mutational analysis of the double-stranded RNA (dsRNA) binding domain of the dsRNA-activated protein kinase, PKR
28. Genetically engineered poxviruses for recombinant gene expression, vaccination, and safety
29. Host range restricted, non-replicating vaccinia virus vectors as vaccine candidates
30. Structure of the double-stranded RNA-binding domain of the protein kinase PKR reveals the molecular basis of its dsRNA-mediated activation
31. Multigenic evasion of inflammation by poxviruses
32. Safe and effective poxvirus vectors-NYVAC and ALVAC
33. A simple method of estimating fifty percent endpoints
34. Vaccinia virus E3L protein is an inhibitor of the interferon (i.f.n.)-induced 2-5A synthetase enzyme
35. Inhibition of double-stranded RNA-dependent protein kinase PKR by vaccinia virus E3: Role of complex formation and the E3 N-terminal domain
36. Molecular basis of double-stranded RNA-protein interactions: Structure of a dsRNA-binding domain complexed with dsRNA
37. The PKR protein kinase-an interferon-inducible regulator of cell growth and differentiation
38. Role of the vaccinia virus E3L and K3L gene products in rescue of VSV and EMCV from the effects of IFN-alpha
39. Vaccinia virus immune evasion
40. Vaccinia virus encodes a family of genes with homology to serine proteinase inhibitors
41. Immune modulation by proteins secreted from cells infected by vaccinia virus
42. A conserved double-stranded RNA-binding domain
43. Safety and immunogenicity of recombinants based on the genetically-engineered vaccinia strain, NYVAC
44. Respiratory infection of mice with vaccinia virus
45. Encoding of a homolog of the IFN-gamma receptor by myxoma virus
46. Characterization of a vaccinia virus-encoded double-stranded RNA-binding protein that may be involved in inhibition of the double-stranded RNA-dependent protein kinase
47. A "string-of-beads" vaccine, comprising linked minigenes, confers protection from lethal-dose virus challenge
48. PKR; a sentinel kinase for cellular stress
49. Biological characterization of recombinant vaccinia viruses in mice infected by the respiratory route
50. Nuclear localization of a double-stranded RNA-binding protein encoded by the vaccinia virus E3L gene